Search clinical trials for: TGR-1202 Obinutuzumab Chlorambucil
Total 58 results
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Weill Medical College of Cornell UniversityTG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | CLL/SLL | CLL ProgressionUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Poland, Italy, United Kingdom
-
TG Therapeutics, Inc.TerminatedStudy to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular LymphomaFollicular Lymphoma | Small Lymphocytic LymphomaUnited States
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
TG Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterCompletedChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaAustralia, Poland
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.CompletedWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Non Follicular Indolent Non-Hodgkin LymphomaUnited States
-
Columbia UniversityTG Therapeutics, Inc.Terminated
-
University of Alabama at BirminghamTerminated
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
TG Therapeutics, Inc.CompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingPolycythemia Vera | MyelofibrosisUnited States
-
TG Therapeutics, Inc.Terminated
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Italy, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Thailand, Romania, Croatia, Brazil, Arge... and more
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Italy, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Thailand, Romania, Croatia, Brazil, Arge... and more
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Italy, Thailand, Romania, Croatia, Brazil, Arge... and more
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research...Active, not recruitingMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Hoffmann-La RocheCompleted
-
Massachusetts General HospitalTG TherapeuticsActive, not recruitingLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
Pharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small-Cell LymphomaUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
CelgeneCompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinFrance, Italy, Netherlands
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, Spain, Poland, United Kingdom, Australia, Belgium, Canada
-
TG Therapeutics, Inc.CompletedHodgkin's LymphomaUnited States
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.MediBeaconCompletedKidney Diseases | Kidney Injury | Kidney FailureChina
-
Hoffmann-La RocheAbbVie; German CLL Study GroupActive, not recruitingLymphocytic Leukemia, ChronicUnited States, Spain, France, United Kingdom, Australia, Canada, Denmark, Germany, Italy, Brazil, Argentina, Estonia, New Zealand, Austria, Bulgaria, Croatia, Romania, Russian Federation, Poland, Switzerland, Mexico
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, Belgium, Brazil, Poland, United Kingdom, Canada, Germany, Australia, Israel, Hungary, France, New Zealand, Chile, Lithuania, Sweden, Colombia
-
MediBeaconRecruitingKidney Diseases | Kidney Injury | Kidney FailureUnited States
-
MediBeaconCompleted
-
Hoffmann-La RocheTerminatedB-Cell Chronic Lymphocytic LeukemiaItaly, Spain, Israel, United Kingdom, Latvia
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLeukemia, Lymphocytic, Chronic, B-CellCanada, Belgium, Netherlands, Spain, Israel, United States, Czechia, Denmark, United Kingdom, France, Russian Federation, Turkey, Poland, Sweden
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
University of WashingtonTG Therapeutics, Inc.TerminatedHodgkin's LymphomaUnited States
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaItaly, Sweden, Belgium, Brazil, Canada, Germany, Ireland, Korea, Republic of, Spain, Russian Federation, France, Finland, Israel, Estonia, Romania, Egypt, Thailand, Switzerland, Bosnia and Herzegovina, Slovakia, Turkey, Lithuania, P... and more
-
Yazeed SawalhaWithdrawnRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
TCRCure Biopharma Ltd.Fudan UniversityRecruiting
-
Mie UniversityFiverings Co., Ltd.; Shionogi; Takara Bio Inc.; Statcom Co. Ltd.Completed